MLoptic

MLoptic EBITDA Growth YoY

The Year-over-Year EBITDA Growth of MLoptic (688502.SS) as of Nov 2, 2026 is 40.04 %. In the previous year, Year-over-Year EBITDA Growth was 0.58 % — a change of 6,752.09% (higher).

EBITDA Growth YoY

40.04 %

YoY

6,752.09%

Last updated:

Year-over-Year EBITDA Growth of MLoptic is 2025 40.04 % . Year-over-Year EBITDA Growth of MLoptic was 2024 0.58 % . It decreases by 6,752.09% higher compared to the previous year.

The MLoptic EBITDA Growth YoY history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA Growth YoY
Date
EBITDA Growth YoY
Jan 1, 2019
409.77 CNY
Jan 1, 2020
13.72 CNY
Jan 1, 2021
18.81 CNY
Jan 1, 2022
9.17 CNY
Jan 1, 2023
-17.34 CNY
Jan 1, 2024
0.58 CNY
Jan 1, 2025
40.04 CNY
The MLoptic EBITDA Growth YoY history
YEAREBITDA Growth YoYYoY
40.04 %+6,752.09%
0.58 %-103.37%
-17.34 %-289.08%
9.17 %-51.24%
18.81 %+37.09%
13.72 %-96.65%
409.77 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

MLoptic Stock analysis

What does MLoptic do? MLOptic Corp. generates revenue through the research, development, design, manufacturing, and sales of precision optical devices, high-end optical lenses, and advanced optical systems. The company's main products include precision optics such as lenses, prisms, and plates, optical lenses like microscope objective lenses, machine vision lenses, imaging lenses, and monitoring lens series, and optical systems comprising semiconductor detection optical modules, medical detection optical system modules, biometric optical modules, augmented reality technology, virtual reality technology optical test modules, and optical detection equipment. These products are sold in both domestic and foreign markets to customers requiring high-precision optical solutions for industrial, medical, and technology applications. The firm targets industrial, medical, and technology sectors as key segments, with customers purchasing precision optics for manufacturing processes, optical lenses for machine vision and imaging applications, and optical systems for semiconductor and medical detection. The company's product portfolio serves diverse applications including semiconductor detection, medical diagnostics, biometric systems, and augmented and virtual reality technologies, ensuring steady demand across multiple high-tech industries. MLOptic Corp. focuses on delivering specialized optical components and systems that address specific technical challenges in advanced manufacturing and medical technology. By offering tailored solutions for semiconductor detection, medical diagnostics, and biometric identification, the company captures value in niche markets where precision and reliability are critical. This approach allows the company to maintain strong customer relationships and recurring revenue streams within its target sectors. MLoptic is one of the most popular companies on Eulerpool.

Frequently Asked Questions about MLoptic stock

Year-over-Year EBITDA Growth of MLoptic is 40.04 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year EBITDA Growth MLoptic since 2006 – with annual values, charts, and detailed analysis.

EBITDA growth measures the percentage change in EBITDA compared to the prior year. It shows changes in operating cash earnings before capital structure effects.

To evaluate Year-over-Year EBITDA Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year EBITDA Growth.

Year-over-Year EBITDA Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year EBITDA Growth's MLoptic historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — MLoptic

All Key Metrics — MLoptic